山河药辅
(300452)
| 流通市值：24.12亿 | | | 总市值：30.27亿 |
| 流通股本：1.87亿 | | | 总股本：2.34亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 184,674,669.46 | 221,148,297.23 | 192,690,005.5 | 138,597,190.08 |
| 交易性金融资产 | 523,010,381.07 | 475,107,347.9 | 515,633,361.74 | 491,252,134.3 |
| 应收票据及应收账款 | 178,741,208.89 | 206,188,618.12 | 151,185,929.75 | 175,686,453.85 |
| 其中：应收票据 | 44,668,504.91 | 47,474,529.09 | 44,920,193.97 | 43,942,462.62 |
| 应收账款 | 134,072,703.98 | 158,714,089.03 | 106,265,735.78 | 131,743,991.23 |
| 应收款项融资 | 49,330,708.59 | 46,735,501.29 | 53,544,169.81 | 33,675,438.56 |
| 预付款项 | 11,734,177.44 | 16,737,381.2 | 11,069,250.11 | 29,984,409.23 |
| 其他应收款合计 | 1,043,815.17 | 901,858.42 | 1,050,572.41 | 826,590.2 |
| 存货 | 88,827,407.64 | 81,234,134.67 | 88,758,572.74 | 98,777,247.13 |
| 其他流动资产 | 6,326,154.21 | 7,101,755.48 | 7,600,006.15 | 6,034,874.21 |
| 流动资产合计 | 1,043,688,522.47 | 1,055,154,894.31 | 1,021,531,868.21 | 974,834,337.56 |
| 非流动资产: | | | | |
| 固定资产 | 453,429,557.86 | 464,584,220.38 | 464,905,884.26 | 464,404,726.81 |
| 在建工程 | 31,703,775 | 4,675,551.18 | 11,543,011.58 | 14,751,576.4 |
| 无形资产 | 55,692,969.95 | 56,045,253.71 | 51,224,727.66 | 51,397,804.81 |
| 商誉 | - | - | - | 39,126,854.84 |
| 长期待摊费用 | 1,834,459.38 | 2,013,779.7 | 2,193,100.02 | 1,480,827.41 |
| 递延所得税资产 | 5,945,789.66 | 5,928,041.17 | 5,959,272.94 | 6,769,794.88 |
| 其他非流动资产 | 3,173,408.92 | 2,089,829.76 | 2,372,523.47 | 4,142,093.96 |
| 非流动资产合计 | 551,779,960.77 | 535,336,675.9 | 538,198,519.93 | 582,073,679.11 |
| 资产总计 | 1,595,468,483.24 | 1,590,491,570.21 | 1,559,730,388.14 | 1,556,908,016.67 |
| 流动负债: | | | | |
| 短期借款 | 6,514,884.2 | 15,297,999.2 | 6,461,053.06 | 20,338,711.12 |
| 应付票据及应付账款 | 193,885,619.67 | 159,648,552.85 | 186,088,782.6 | 177,497,798.34 |
| 其中：应付票据 | 113,287,619.3 | 106,832,457.3 | 108,641,087 | 111,111,194.6 |
| 应付账款 | 80,598,000.37 | 52,816,095.55 | 77,447,695.6 | 66,386,603.74 |
| 预收款项 | 88,875 | 118,305 | 108,405 | 92,265 |
| 合同负债 | 5,918,291.28 | 4,443,772.43 | 6,978,017 | 3,798,745.34 |
| 应付职工薪酬 | 8,024,731.44 | 7,959,569.07 | 14,861,514.57 | 7,841,069.93 |
| 应交税费 | 9,992,884.96 | 6,367,055.67 | 2,133,256.77 | 9,079,526.55 |
| 其他应付款合计 | 515,803 | 434,920.17 | 338,865.02 | 690,187.58 |
| 其他流动负债 | 16,932,014.01 | 19,488,675.38 | 16,504,886.28 | 19,301,896.45 |
| 流动负债合计 | 241,873,103.56 | 213,758,849.77 | 233,474,780.3 | 238,640,200.31 |
| 非流动负债: | | | | |
| 应付债券 | 304,103,406.49 | 301,352,710.26 | 298,514,925.63 | 296,432,271.87 |
| 递延收益 | 33,795,418.33 | 34,999,955.64 | 33,492,159.62 | 32,584,363.6 |
| 递延所得税负债 | 21,646,568.25 | 18,062,901.41 | 18,948,759.79 | 11,065,138.62 |
| 非流动负债合计 | 359,545,393.07 | 354,415,567.31 | 350,955,845.04 | 340,081,774.09 |
| 负债合计 | 601,418,496.63 | 568,174,417.08 | 584,430,625.34 | 578,721,974.4 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 234,449,487 | 234,448,828 | 234,448,462 | 234,447,103 |
| 其他权益工具 | 30,035,261.72 | 35,340,198.13 | 35,340,750.63 | 35,342,794.86 |
| 资本公积 | 65,521,835.22 | 65,513,020.9 | 65,508,162 | 66,930,499.78 |
| 减:库存股 | 22,505,816.02 | 22,505,816.02 | 22,505,816.02 | 22,505,816.02 |
| 专项储备 | 604,496 | 381,587.13 | 67,327.74 | 63,207.71 |
| 盈余公积 | 103,813,602.04 | 103,813,602.04 | 103,813,602.04 | 89,202,812.63 |
| 未分配利润 | 511,585,263.91 | 535,514,203.66 | 488,337,307.97 | 505,949,215.15 |
| 归属于母公司股东权益合计 | 923,504,129.87 | 952,505,623.84 | 905,009,796.36 | 909,429,817.11 |
| 少数股东权益 | 70,545,856.74 | 69,811,529.29 | 70,289,966.44 | 68,756,225.16 |
| 股东权益合计 | 994,049,986.61 | 1,022,317,153.13 | 975,299,762.8 | 978,186,042.27 |
| 负债和股东权益合计 | 1,595,468,483.24 | 1,590,491,570.21 | 1,559,730,388.14 | 1,556,908,016.67 |
| 公告日期 | 2025-08-27 | 2025-04-23 | 2025-04-23 | 2024-10-23 |
| 审计意见(境内) | | | 标准无保留意见 | |